Wegovy Cuts Risk of Heart Problems, Novo Nordisk Trial Says

A clinical trial was the first to demonstrate that a new obesity drug could also improve patients’ heart health.

Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.